CD40-activated macrophages become highly susceptible to X4 strains of human immunodeficiency virus type 1

被引:14
作者
Bakri, Y
Mannioui, A
Ylisastigui, L
Sanchez, F
Gluckman, JC
Benjouad, A
机构
[1] Hop St Antoine, INSERM, EPI 0013, Immunol Lab,Inst Univ Hematol, F-75571 Paris 12, France
[2] Fac Sci Rabat, Lab Biochim Immunol, Agcy Univ Francophone, Rabat, Morocco
关键词
D O I
10.1089/08892220252779647
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activating cells of the immune system may stimulate human immunodeficiency virus type 1 (HIV-1) replication and contribute to select pathogenic variants,in vivo. Here, we; examined the possible effect of a major pathway of immune activation, CD40 interaction with its ligand (CD40L), on the susceptibility of monocyte-derived macrophages (MDMs) to various HIV-1 strains. Stimulation of MDMs with CD40L led to reduced replication of R5 HIV-1(Ba-L), whereas this strongly enhanced the replication of X4 HIV-1(Lai) as well as of X4 primary isolates, and this was associated with strong cytopathic effects, The replication of X4 strains was inhibited by stromal cell-derived factor 1, an indication of the restricted usage of CXCR4 as virus coreceptor in this case. CD40L induced the activation of mitogen-activated protein kinases ERK1/ERK2 and stimulated MDMs to secrete RANTES (regulated on activation, normal T cell expressed and secreted), macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, interleukin 6 (IL-6), IL-1beta, and tumor necrosis factor alpha. From this data, it may be hypothesized that activated macrophages represent a favorable environment for the replication of classically T lymphocyte-tropic X4 variants and, thus, may contribute significantly to the selection of such variants at late stages of clinical HIV-1 infection.
引用
收藏
页码:103 / 113
页数:11
相关论文
共 56 条
[1]   The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state [J].
Amzazi, S ;
Ylisastigui, L ;
Bakri, Y ;
Rabehi, L ;
Gattegno, L ;
Parmentier, M ;
Gluckman, JC ;
Benjouad, A .
VIROLOGY, 1998, 252 (01) :96-105
[2]   CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes [J].
Arthos, J ;
Rubbert, A ;
Rabin, RL ;
Cicala, C ;
Machado, E ;
Wildt, K ;
Hanbach, M ;
Steenbeke, TD ;
Swofford, R ;
Farber, JM ;
Fauci, AS .
JOURNAL OF VIROLOGY, 2000, 74 (14) :6418-6424
[3]   Induction of activator protein 1 (AP-1) in macrophages by human immunodeficiency virus type-1 NEF is a cell-type-specific response that requires both Hck and MAPK signaling events [J].
Biggs, TE ;
Cooke, SJ ;
Barton, CH ;
Harris, MPG ;
Saksela, K ;
Mann, DA .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 290 (01) :21-35
[4]   Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor [J].
Brossart, P ;
Grünebach, F ;
Stuhler, G ;
Reichardt, VL ;
Möhle, R ;
Kanz, L ;
Brugger, WR .
BLOOD, 1998, 92 (11) :4238-4247
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA EXPRESSION BY 4 CHRONICALLY INFECTED CELL-LINES INDICATES MULTIPLE MECHANISMS OF LATENCY [J].
BUTERA, ST ;
ROBERTS, BD ;
LAM, L ;
HODGE, T ;
FOLKS, TM .
JOURNAL OF VIROLOGY, 1994, 68 (04) :2726-2730
[6]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[7]   In vivo CD40-CD154 (CD40 ligand) interaction induces integrated HIV expression by APC in an HIV-1-transgenic mouse model [J].
Chougnet, C ;
Freitag, C ;
Schito, M ;
Thomas, EK ;
Sher, A ;
Shearer, GM .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3210-3217
[8]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[9]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[10]   FAS AND TUMOR-NECROSIS-FACTOR RECEPTOR-MEDIATED CELL-DEATH - SIMILARITIES AND DISTINCTIONS [J].
CLEMENT, MV ;
STAMENKOVIC, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :557-567